GC
CELG

Grace Capital’s Celgene Corp CELG Stock Holding History

Grace Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-900
Closed -$83K – 193
2019
Q2 		$83K Sell
900
-800
-47% -$76K 0.04% 166
2019
Q1 		$160K Hold
1,700
– – 0.06% 171
2018
Q4 		$109K Buy
1,700
+900
+113% +$66.4K 0.05% 184
2018
Q3 		$72K Hold
800
– – 0.03% 187
2018
Q2 		$64K Buy
+800
New +$66.4K 0.02% 199

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Grace Capital's CELG Position: Q3 2019 in Review

Grace Capital sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 900 shares — an estimated $83K sold.

Grace Capital first reported a position in CELG in Q2 2018 and held it in 5 quarters. The position peaked at $160K in Q1 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Grace Capital reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Grace Capital sold 900 Celgene Corp shares in Q3 2019, an estimated $83K.
  • Grace Capital first reported a position in Celgene Corp in Q2 2018 and held it in 5 quarters.
  • Grace Capital's Celgene Corp position peaked at $160K in Q1 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Grace Capital's 13F filing for Q3 2019, filed 15 Nov 2019.